Publisher： Bentham Science Publishers
E-ISSN： 2212-4055|11|4|330-334
ISSN： 1871-5281
Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.11, Iss.4, 2012-08, pp. : 330-334
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Vaccines linked to Guillain-Barre syndrome
Reactions Weekly, Vol. 1, Iss. 1164, 2007-01 ,pp. :
Access to resources
Recommend
Efalizumab: Guillain-Barre syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1226, 2008-01 ,pp. :
Infliximab: Guillain-Barre syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1106, 2006-01 ,pp. :
Infliximab: Guillain-Barre syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1196, 2008-01 ,pp. :
Hepatitis A vaccine: Guillain-Barre syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1323, 2010-01 ,pp. :